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Abstract
Background: Vascular disease is common in patients with chronic renal failure as well as in 
patients with renal transplantation. It is a common cause of death in these patients. One possible 
factor for this increased incidence of vascular disease is hyperlipidaemia that frequently occurs in 
these patients. 
Purpose: To determine the lipoprotein pattern in patients with chronic renal failure and patients
who had renal transplantation in our community. 
Methods: 78 patients, age ranging between 10-75 years (mean value of 42.7) were studied. They
were 21 pre-dialysis patients, 42 dialyzed patients (20 peritoneal dialysis and 22 Haemodialysis), 
and 15 patients following renal transplantation. Fasting blood Cholesterol, triglyceride, high and 
low density lipoprotein (HDL and LDL) were determined.  
Results: 2 patients of the pre-dialysis group had high cholesterol levels, while 6 patients had high triglyceride levels
and 7 patients had high serum HDL levels. Only 9 patients had ischaemic changes on E.C.Gs. 3(7.3%) patients on
dialysis group had high cholesterol levels, 11.9% had high triglyceride levels. 24 patients of the dialysis group had 
ischaemic changes in E.C.G. 7 transplant patients had high serum triglyceride levels and only two have elevated LDL.
Chronic renal failure is commonly
accompanied by hypertriglyceridemia or
combined hyperlipidemia with low levels of high
density lipoproteins (HDL), but cholesterol levels
in plasma are usually normal. Hepatic endothelial 
lipase activity is also low and there is commonly
insulin resistance1. After renal transplanatation 
hypercholesterolemia appears probably due to the 
corticosteroid therapy2. Atherosclerotic
cardiovascular disease is the major cause of death
among these patients. This may be related to their
lipid abnormalities3.  Patients undergoing
Haemodialyis receive large amount of intravenous
heparin. Heparin stimulates release of lipoprotein 
lipase into bloodstream. Repeated heparin 
infusions could deplete tissues of this enzyme2.
Methods
The study was conducted in Ibn Sina 
Hospital and Khartoum Teaching Hospital, renal 
unit from Dec 1998 through March 1999. 78
patients were categorized as follows:
1. Pre-dialysis patients: 21 patients with ages
ranged between 13-67 years. They were 76.2%
males, and 23.8% females. 
2. Patients on dialysis: 17 males and three 
females on peritoneal dialysis. Their age ranged 
between 21-60 years with 18 males and four
females on haemodialysis. Their age ranged 
between 15-60 years.  
1. Senior dietitian in Ibn Sina Hospital 
2. Consultant nephrologist Ibn Sina Hospital 
3. Vice Chancellor,  Juba University. 
3. Transplant patients were13 males and two 
females, their ages ranged between-15-60 years.  
All patients had cholesterol, triglyceride,
high-density lipoprotein (HDL) low density
lipoprotein (LDL), very low-density lipoprotein 
(VLDL) and ECG done.
Five ml venous blood was collected after
over night fast. The blood was allowed to clot for
one hour at room temperature, and then 
centrifuged at 5000 r.p.m for 10 minutes. Serum
was withdrawn by pipette and kept into tightly
covered containers at – 20oC till used for
estimation of serum triglyceride, serum total 
cholesterol and serum lipoproteins.  
Chemicals used were commercial kits
obtained from Crescent Diagnostic (Saudi
Arabia).  Triglyceride kit Cat No. Cs 611.  
Cholesterol kit Cat No. CS 603. HDL precipitant 
Cat No. CS 606. MSE Micro centrifuge was used 
for the separation of HDL fraction in the serum. 
Corning colorimeter model 252 was used to 
estimate serum triglyceride, serum total 
cholesterol and serum HDL. Serum triglyceride 
concentration was measured using enzymatic
methods4. The working reagent was prepared by
dilution of one part of the enzyme concentrate 
with 100 parts of the buffer (1 ml/100 ml) mixed 
gently and allowed to equilibrate at room
temperature. When combined as instructed, the 
working reagent contains the following: Buffer at
PH 7.5 40 mmol /1, Lipase >150 JY.1, Glycerol 
kinas >0.4 KU/1, Glycerol-3-phospahte oxidase 
>1.5 KU/1, Peroxidase >0.5 KU/1, Magnesium 5
mmol/1, adenosine triphosphate (ATP) 1 mmol/1, 
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Chlorophenol 5 mmol/1, Aminoantipyrine 0.4 
mmol/1, stabilizers and preservatives.
Serum triglycerides are hydrolyzed by the 
enzyme lipase to yie l d glycerol and free fatty
acids. The released glycerol is assayed in reaction
catalyzed by the enzymes glycerol kinase, 
glycerol-3-phosphate oxidase in a system that 
generates hydrogen peroxide. The hydrogen 
peroxide is monitored in the presence of
peroxidase with 4- aminoantipyrine and 
chlorophenol as a chromogenic system. The end
product is a quinine amine dye, the concentration 
of which at 540 nm is directly proportional to the 
concentration of triacylglyceride concentration in 
the sample.  
One ml of the working reagent was pipetted 
into three test tubes labeled test, standard and 
blank.  0.1ml of the sample was pipetted into the 
test tube. 0.01ml was pipetted into the standard
tube and 0.01 ml of distilled water was pipetted 
into the blank one using micro pipette. All the 
above tubes were incubated at 37oC for 5 minutes.
Then the absorbency of the sample and that of the 
standard were measured against the reagent blank
using the colorimeter at wavelength 540 nm
within 60 minutes.
Cholesterol estimation: The enzyme reagent
contains: Phosphate buffer (PH 6.5) 30 mmol/1,
4- aminoantipyrine 0.25 mmol/1, Phenol 5 
mmol/1, Peroxidase > 10 KU/1, Cholesterol
esterase >350 U/1 and Cholesterol oxidase
>140 U/1.
Cholesterol esterase catalyzes the 
hydrolysis of cholesterol esters to produce 
cholesterol and free fatty acids. The produced 
cholesterol is oxidized by the cholesterol oxidase 
to produce cholest 4-en zone and hydrogen 
peroxide.  Hydrogen peroxide couples with 4-
aminoantipyrine and phenol in the presence of
peroxidase to produce quinone amine dye which 
is a chromgen red in color. The absorbency of the 
dye at 540 nm is directly proportional to the 
concentration of cholesterol in the sample.  
The absorbency of the sample and the absorbency 
of the standard were measured against the reagent
blank using the colorimeter at wavelength 550 nm 
within 60 minutes.
Estimation of High Density Lipoprotein using
phosphotuagestic acid precipitation method.
Reagent composition: Phosphotungestic acid 0.55
mmol /I. Magnesium ions 25.0 mmol/1.
Phosphotungestic acid and magnesium ions 
specifically precipitate LDL and VLDL. After 
centrifugation, the cholesterol contents of HDL
supernatant (HDL-Con) is determined using the 
cholesterol kit. 
Reagent preparation: Four parts of the reagent 
were diluted with one part of distilled water (20 
ml of distilled water were added to 80 ml of the 
reagent). 
Precipitation into a micro centrifuge tube 
0.5 ml of the reagent and 0.2 ml of the sample 
were pipetted, the tube was mixed, allowed to 
stand for 10 minutes at room temperature and
centrifuged for 10 minutes at 4000 r.p.m using
micro centrifuge. Cholesterol content of the HDL
supernatant was determined using Crescent 
Diagnostics kit Cat, No. Cs 603. Using
micropipettes, 1 ml of the reagent and 0.1 ml of
the sample were pipetted into a test tube labeled 
test, into another test tube labeled blank 1 ml of
the reagent and 0.1 of distilled water were 
pipetted. Both the test tube and the blank were 
incubated at 30OC for 10 minutes. Then the 
absorbency of the sample was measured against 
the reagent blank using colorimeter at wavelength 
540 nm within 30 minutes.
RESULTS 
Pre-dialysis patients: 19 patients had value 
equal to or less than 200 mg/dl while 2 patients 
had high cholesterol level ranging between 250-
300 mg/dl.
The normal value of serum HDL is more 
than 55 mg/dl in males, and more than 65 mg/dl in 
females. Serum HDL level in 10 patients ranged 
between 10-50 mg/dl. In four females it was 65 
mg/dl and in six of both sexes it ranged between 
80-100 mg/dl.
Out of the 21 patients there were 9 who had 
ischemic changes in E.C.G. Only 4 patients out of
them had low serum HDL levels, 3 patients with 
borderline HDL levels and one had high serum 
HDL level. Most patients had normal serum LDL
and only one patient exceeded the normal value 
(256.3 mg/dl).  
The peritoneal dialysis patients:
11 females had high serum HDL levels 
between 60-65 mg/dl. Only 4 males had low
serum HDL levels, and 4 females had borderline 
HDL. One female had low serum HDL level. Out 
of 21 patients 13 patients had ECG ischemic
changes. Seven males had high serum HDL. Two 
women had serum HDL levels 68.5 mg/dl. All 
patients have normal value of LDL except one 
who exceeded the normal value. Most of the 
patients have normal very low density lipoprotein 
(VLDL) levels.
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Heamodialysis patients:- 
 Six out of 22 patients had history of 
hypertension. 19 out of 22 patients had serum 
cholesterol levels within normal value i.e. equal or 
less than 200 mg/dl. Two had values ranging 
between 200-240 mg/dl. Only one patient had 
high cholesterol value (300 mg/dl). All this group 
of patients had serum triglyceride levels within 
the normal value, which ranges between 30-165 
mg/dl. The majority of patients (18) had low 
serum HDL levels. 4 patients (all of them 
females) had high serum HDL levels. Out of 22 
patients there were 11 patients with ischemic 
changes in the E.C.G, 8 of them had low serum 
HDL values. Three patients had ischemic changes 
in the E.C.G with normal or high serum HDL 
value. Out of those 11 patients there were 4 with 
minor ischemic changes. 7 Patients had major 
ischemic changes. Most of the patients had 
normal serum LDL levels; only one exceeded the 
normal value. All patients had normal VLDL 
levels.  
Transplant Patients:  
 The majority of patients (60%) had their 
transplant for more than 3 years. 3 patients had it 
for 7-12 months. 2 patients had it for 25-30 
months. Only one patient had it for less than 6 
months. 53.3% of the patients were not diabetic 
two patients developed diabetes mellitus after the 
transplantation. Five patients had history of DM 
before transplantation. 33.3% are hypertensive.  
 11 patients had normal value of blood 
glucose levels. Three patients who were diabetic 
had blood glucose levels 260-325 mg/dl. 5 male 
patients had major ECG schematic changes, but, 
their serum HDL levels were normal.  
 Most patients had serum cholesterol level 
equal to or less than 200 mg/dl. Only one patient 
had serum cholesterol level 233.3 mg/dl.  
 Serum triglyceride in eight patients was 
within normal. Seven patients had 
hypertriglycerdeamia ranging between 180-330 
mg/dl.  
Discussion: 
       Vascular disease is common in patients with 
chronic renal failure as well as in patients with 
renal transplantation. It is a common cause of 
death in these patients. Disturbance of lipid 
profile is a well known risk factor for these 
vascular diseases. A lot of work was done to 
determine lipid disorder in different populations 
of renal disease. Seventeen out of nineteen 
patients in the predialysis group in this study had 
high cholesterol level. This finding is similar to 
literature and earlier studies5. Unlike previous 
reports most patients in this group had normal 
value of HDL and only 5 patients exceeded the 
normal value of triglyceride6.  Most of our 
patients have normal VLDL levels but four 
exceeded the normal value. This is not consistent 
with the others findings. In the haemodialysis 
group only one patient had high cholesterol value. 
All this group of patients had serum triglyceride 
levels within the normal value. This observation is 
rather different from other researches. In 
agreement with earlier studies, 18 patients in this 
study had low serum HDL levels but 4 (all of 
them females) had high serum HDL levels7.  Out 
of 22 patients there were 11 patients with 
ischemic changes in the E.C.G, 8 of them had low 
serum HDL values. However all patients had 
normal VLDL levels; which is different from a 
similar work done elsewhere2,8. Consistent with 
other studies, most patients in the transplant group 
had serum cholesterol within normal limits apart 
from one patient. Never the less, different results 
were found by other workers 2,5.  
 Serum triglyceride in eight patients was 
within normal but seven patients had 
hypertriglycerdeamia ranging between 180-330 
mg/dl. This finding is in agreement with literature 
2,4.  
Conclusion  
 We conclude that most patients with 
chronic renal failure who are on conservative 
management have normal values of lipoproteins. 
 The majority of patients on peritoneal 
dialysis had normal values of lipoproteins. Seven 
of them had ECG ischemic changes while two had 
ischemic changes with borderline levels.  
 With the exception of one, patients on 
haemodialysis had normal value of lipoproteins, 
(this one patient had high cholesterol level). All 
patients had normal triglyceride and serum VLDL 
levels. Most patients had normal serum LDL 
levels, only one exceeded the normal value. 
 Although corticosteroids and cyclosporine 
are the major causes of hyperlipidaemia in 
transplant patients, in this study all patients had 
normal levels of cholesterol, LDL, triglyceride 
and VLDL except 4 patients who exceeded  the 
normal VLDL value. Seven patients had high 
HDL levels three of them had ECG ischemic 
changes. 
 Although high HDL levels protect against the 
risks of coronary heart disease we found that 17 
patients out of 78 had ECG ischemic changes with 
high HDL value.   
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 Our hypotheses is that the major causes 
for these results of lipoprotein pattern are related 
to the Sudanese diet which tends to be low in fat 
as well as an unidentified role for genetic factors 
e.g. more potent lipase enzyme, or may be due to 
some abnormalities in lipoprotein’s carriers.  
Recommendations 
Lipoproteins investigation should be done for all 
patients who suffer from chronic renal failure as 
well as for patients who had renal transplant as a 
routine test. E.C.G has to be done for those 
patients from time to time for early diagnosis of 
ischemic heart disease. The patients must be 
referred to the dietician for dietary management 
and follow up.  
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